Learning with COVID-19: what about anticoagulation?

Authors

  • E. Álvarez-Rodríguez Servicio de Urgencias. Hospital Universitario Severo Ochoa. Leganés, Madrid.
  • R. González González Servicio de Urgencias. Hospital Universitario Severo Ochoa. Leganés, Madrid.
  • R. Torres-Gárate Servicio de Urgencias. Hospital Universitario Severo Ochoa. Leganés, Madrid.
  • P. López-Riquelme Servicio de Urgencias. Hospital Universitario Severo Ochoa. Leganés, Madrid.
  • I. González Martil Servicio de Urgencias. Hospital Universitario Severo Ochoa. Leganés, Madrid.
  • V. Abad Cuñado Servicio de Urgencias. Hospital Universitario Severo Ochoa. Leganés, Madrid.

DOI:

https://doi.org/10.23938/ASSN.0884

Keywords:

SARS-CoV-2., COVID-19., Anticoagulation., Abdominal hematoma.

Abstract

Infection caused by SARS-CoV-2 (COVID-19) is associated with an increased risk of thromboembolic disease. Some authors recommend anticoagulation at therapeutic doses for, at least, the most severely ill patients; this practice is not free of risks, which is why only thromboembolic prophylaxis is recommended by other consensuses. In the case of previously anticoagulated patients, changing the oral anticoagulant for a low molecular weight heparin (LMWH) is generally recommended.

We present the cases of two patients admitted due to COVID-19, without serious clinical data, in whom anticoagulation (acenocoumarol and rivaroxaban, respectively) was replaced by LMWH at therapeutic doses, both presenting abdominal bleeding. This type of bleeding is an infrequent complication in anticoagulated patients, but the concurrence of two cases in a short period of time in the context of the COVID-19 pandemic leads us to consider that there is not yet any clear evidence on therapeutic anticoagulation in SARS-CoV-2 infection.

Downloads

Download data is not yet available.

Downloads

Published

2020-08-31

How to Cite

Álvarez-Rodríguez, E., González González, R., Torres-Gárate, R., López-Riquelme, P., González Martil, I., & Abad Cuñado, V. (2020). Learning with COVID-19: what about anticoagulation?. Anales Del Sistema Sanitario De Navarra, 43(2), 251–254. https://doi.org/10.23938/ASSN.0884

Issue

Vol. 43 No. 2 (2020): May-August 2020

Section

Clinical notes

License

Copyright (c) 2020 Anales del Sistema Sanitario de Navarra

Creative Commons License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

La revista Anales del Sistema Sanitario de Navarra es publicada por el Departamento de Salud del Gobierno de Navarra (España), quien conserva los derechos patrimoniales (copyright ) sobre el artículo publicado y favorece y permite la difusión del mismo bajo licencia Creative Commons Reconocimiento-CompartirIgual 4.0 Internacional (CC BY-SA 4.0). Esta licencia permite copiar, usar, difundir, transmitir y exponer públicamente el artículo, siempre que siempre que se cite la autoría y la publicación inicial en Anales del Sistema Sanitario de Navarra, y se distinga la existencia de esta licencia de uso.

Most read articles by the same author(s)